ACC Asks EPA to Withdraw Dioxin Assessment Due to New IRIS Mandate

ACC is asking EPA to withdraw its review of dioxin’s noncancer health effects, saying that recently passed legislation will require the agency to demonstrate how the assessment meets certain recommendations issued last April by the National Academy of Sciences (NAS; Washington). “To comply with Congress’s direction, EPA should withdraw the dioxin assessment from interagency review and take the necessary steps to implement the NAS recommendations,” says ACC president and CEO Cal Dooley in a recent letter to EPA administrator Lisa Jackson...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers